- Home
- THAR vs ASST Comparison
THAR vs ASST Comparison
Compare THAR & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- ASST
- Stock Information
- Founded
- THAR 2017
- ASST 2020
- Country
- THAR United States
- ASST United States
- Employees
- THAR N/A
- ASST N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- ASST Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- ASST Technology
- Exchange
- THAR Nasdaq
- ASST Nasdaq
- Market Cap
- THAR 2.8M
- ASST 2.7M
- IPO Year
- THAR 2022
- ASST 2023
- Fundamental
- Price
- THAR $2.13
- ASST $0.47
- Analyst Decision
- THAR
- ASST
- Analyst Count
- THAR 0
- ASST 0
- Target Price
- THAR N/A
- ASST N/A
- AVG Volume (30 Days)
- THAR 232.7K
- ASST 9.5M
- Earning Date
- THAR 11-07-2024
- ASST 11-14-2024
- Dividend Yield
- THAR N/A
- ASST N/A
- EPS Growth
- THAR N/A
- ASST N/A
- EPS
- THAR N/A
- ASST N/A
- Revenue
- THAR N/A
- ASST $501,584.00
- Revenue This Year
- THAR N/A
- ASST N/A
- Revenue Next Year
- THAR N/A
- ASST N/A
- P/E Ratio
- THAR N/A
- ASST N/A
- Revenue Growth
- THAR N/A
- ASST 93.55
- 52 Week Low
- THAR $1.84
- ASST $0.40
- 52 Week High
- THAR $8.55
- ASST $4.35
- Technical
- Relative Strength Index (RSI)
- THAR 46.63
- ASST 40.73
- Support Level
- THAR $2.09
- ASST $0.41
- Resistance Level
- THAR $2.27
- ASST $0.74
- Average True Range (ATR)
- THAR 0.17
- ASST 0.09
- MACD
- THAR -0.00
- ASST 0.01
- Stochastic Oscillator
- THAR 34.04
- ASST 9.64
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.